Refined structure of dimeric diphtheria toxin 2026

Get Form
Refined structure of dimeric diphtheria toxin Preview on Page 1

Here's how it works

01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send it via email, link, or fax. You can also download it, export it or print it out.

Definition & Meaning

The refined structure of dimeric diphtheria toxin (DT) provides detailed insights into its molecular configuration, aiding in the understanding of its biological function and impact. This refined structure, at a resolution of 2.0 Å, reveals intricate aspects of DT's architecture, which are crucial for its interaction with host cells and potential therapeutic use in immunotoxins. Dimeric DT is a protein-based exotoxin produced by Corynebacterium diphtheriae, exhibiting potent toxicity through inhibition of protein synthesis in host cells.

Key Elements of the Refined Structure

Understanding the components and features of dimeric diphtheria toxin is essential for grasping its function and interaction mechanisms. Key elements include:

  • Subunits and Domains: The structure comprises A and B subunits, with the A subunit responsible for toxic activity and the B subunit facilitating cell entry.
  • Amino Acid Residues: Specific residues play crucial roles in DT's catalytic activity and membrane binding.
  • Binding Interactions: The refined structure elucidates how the toxin interacts with inhibitors, such as adenylyl 3'-5' uridine 3' monophosphate (ApUp).

Functional Implications of the Structure

The molecular architecture of dimeric diphtheria toxin provides insights into its functional dynamics:

  • Catalytic Activity: The arrangement of chemical groups in the active site elucidates how DT inhibits protein synthesis.
  • Membrane Insertion: Structural features of the B subunit facilitate the membrane insertion process, allowing translocation of the A subunit into host cells.
  • Immunotoxin Development: Understanding these interactions aids in designing targeted treatments, utilizing DT as a delivery mechanism for therapeutic agents.

Important Terms Related to the Structure

A comprehensive understanding of this structure requires familiarity with several key terms:

  • Adenylyl 3'-5' Uridine 3' Monophosphate (ApUp): An inhibitor whose binding interactions with DT are crucial for studying the toxin’s functionality.
  • Subunits A and B: Functional modules of the toxin, with distinct roles in toxicity and cellular entry.
  • Catalytic Center: The site within the A subunit responsible for mediating its toxic effects.

Examples of Using the Refined Structure

The refined structure serves as a critical resource in various research and medical applications:

  • Drug Development: Researchers use structural insights to develop inhibitors that can block DT's action.
  • Vaccine Design: Understanding the toxin's structure aids in crafting effective vaccines by neutralizing its active sites.
  • Biotechnology: The toxin’s ability to enter cells is leveraged in designing drug delivery systems, particularly in cancer therapy.

Steps to Complete the Analysis of the Structure

To effectively study and utilize the refined structure of dimeric diphtheria toxin, the following steps are pertinent:

  1. Structural Analysis: Begin by examining the high-resolution 3D structure to identify critical active sites and binding regions.
  2. Functional Studies: Conduct experiments to measure the toxin’s activity and ascertain the roles of specific residues.
  3. Inhibitor Testing: Assess potential inhibitors through computational docking studies and biochemical assays.
  4. Data Interpretation: Integrate findings with biochemical functions to derive meaningful implications for therapeutic development.

Legal Use and Implications

While research and application of the refined structure predominantly fall within scientific and medical jurisdictions, certain legal considerations apply:

  • Patent and Licensing: Innovations involving DT may require patented technologies, necessitating proper licensing for commercial applications.
  • Ethical Compliance: Ensuring ethical standards in research and therapeutic applications is crucial, particularly in human trials and biotechnological uses.

Software Compatibility and Tools for Analysis

Analyzing the refined structure often involves specialized software capable of visualizing and interpreting structural data:

  • Molecular Visualization Software: Tools such as PyMOL or Chimera are commonly used for visualizing DT's structure and simulating interactions.
  • Data Analysis Programs: Software like GraphPad Prism or MATLAB assist in analyzing experimental data related to DT functionality.
be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
Iota toxin, known as AB toxin, is produced by type E strain. B component interacts with the host cell surface receptor to facilitate the uptake of the toxin, while A component inhibits actin polymerization, thereby breaking down the cytoskeleton.
A diphtheria toxin, No. S 15, was prepared with the Park-Wil- liams No. 8 strain of the diphtheria bacillus in medium containing phosphate salts, ammonium lactate, and 2 per cent of peptone, but without meat infusion (6).
The toxin is synthesized as a single polypeptide chain that, after mild trypsin treatment and reduction of a disulfide bond, can be divided into two functionally different moieties: fragment A and fragment B of 21,150 and 37,200 Da, respectively (Pappenheimer, 1977) (Figure 12.5A).
The crystal structure of the diphtheria toxin dimer at 2.5 resolution reveals a Y-shaped molecule of three domains. The catalytic domain, called fragment A, is of the + type.
(a) AB toxins have two moieties: A and B. The A moiety is the active domain with enzymatic activity, while the B domain has the binding receptor property. Depending on the type of AB toxins, they can also have a linker between A and B that usually consists of a peptide and/or a disulfide bond.

Security and compliance

At DocHub, your data security is our priority. We follow HIPAA, SOC2, GDPR, and other standards, so you can work on your documents with confidence.

Learn more
ccpa2
pci-dss
gdpr-compliance
hipaa
soc-compliance

People also ask

The B-fragment of diphtheria toxin binds to cell surface receptors and facilitates entry of the enzymatically active A-fragment into the cytosol.
Corynebacterium diphtheriae infects the nasopharynx or skin. Toxigenic strains secrete a potent exotoxin which may cause diphtheria.
Diphtheria toxin is a single polypeptide chain of 535 amino acids consisting of two subunits linked by disulfide bridges, known as an A-B toxin. Binding to the cell surface of the B subunit (the less stable of the two subunits) allows the A subunit (the more stable part of the protein) to the host cell.

Related links